This book examines the role of genetic toxicology in evaluating the safety of new pharmaceuticals. It covers genotoxicity assays, data interpretation, and regulatory guidelines for assessing the mutagenic and carcinogenic potential of drug candidates. The book emphasizes the integration of genetic toxicology into the drug development pipeline to ensure product safety. Ideal for pharmaceutical scientists and toxicologists, it advances the application of genetic toxicology in creating safe medications.